Release Date: 22/03/12 15:11 Summary: Change in substantial holding - J.P.Morgan Price Sensitive: No Download Document 49.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%